Apply on Employer Site

Adaptive Biotechnologies Corp. · 1 month ago

Research Associate I, Digital Biotechnologies

Seattle, WA

Full-time

Hybrid

Entry Level

$26.88/hr - $40.33/hr

1+ years exp

Adaptive Biotechnologies Corp. is focused on transforming the way diseases are diagnosed and treated through the power of the adaptive immune system. They are seeking a Research Associate I to support the development of a Next Generation Sequencing instrument for clinical medicine, performing experiments and collaborating with scientists to achieve strategic objectives.

BiotechnologyHealth CareTherapeutics

No H1B

Responsibilities

Synthesis and characterization of inorganic and organic nanomaterials

Routine microscopy (e.g., atomic force microscopy (AFM), transmission electron microscopy (TEM), optical microscopy) and image analysis

Prepare samples following a provided experimental plan

Conduct experiments or other related work based on provided protocols

With guidance, collates and interprets data and synthesizes results into a conclusion

Ability to execute experiments efficiently in a wet lab and suggest process improvements

Recognize patterns or inconsistencies when assessing results and share with supervisor

Qualification

Nanomaterials synthesisMicroscopy techniquesMolecular biology techniquesLaboratory experienceTeam collaboration

Required

Bachelor's degree in chemistry, materials science, nanotechnology, engineering (biomedical, chemical, material), physics, or other related field

Applicants should have 1+ years experience working in a laboratory

Ability to work closely and collaboratively with a team of other researchers

Preferred

Experience in nanoparticle, nanomaterials, and/or chemical synthesis

Experience in electron and/or scanning probe microscopy

Experience working with DNA and related molecular biology techniques (e.g., purification, quantification, NGS)

Benefits

Equity grant

Company

Adaptive Biotechnologies Corp.

Glassdoor2.8

Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems.

Founded in 2009

Seattle, Washington, USA

501-1000 employees